BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6606680)

  • 1. Aggressiveness of SJL/J lymphomas correlates with absence of H-2Ds antigens.
    Rosloniec EF; Kuhn MH; Genyea CA; Reed AH; Jennings JJ; Giraldo AA; Beisel KW; Lerman SP
    J Immunol; 1984 Feb; 132(2):945-52. PubMed ID: 6606680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of transplanted SJL/J lymphomas attributed to a single aggressive H-2Ds-negative lymphoma.
    Sopchak L; King SR; Miller DA; Gabra N; Thrush GR; Lerman SP
    Cancer Res; 1989 Feb; 49(3):665-71. PubMed ID: 2910485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of myb expression in an aggressive SJL/J B-cell lymphoma.
    Sopchak L; Thrush GR; Lerman SP; King SR
    Oncogene; 1991 Aug; 6(8):1335-8. PubMed ID: 1886709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
    Bonavida B; Roman JM; Hutchinson IV
    Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive loss Of H-2Ds antigens during passage of a spontaneous SJL/J lymphoma.
    Beisel KW; Lerman SP
    Transplant Proc; 1981 Dec; 13(4):1811-3. PubMed ID: 7330968
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells.
    Brown PH; Thorbecke GJ
    J Immunol; 1985 Nov; 135(5):3572-80. PubMed ID: 3900211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
    Wilbur SM; Marelli O; Bonavida B
    Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-H-2-linked control of in vivo growth of SJL/J-derived reticulum cell sarcoma in recombinant inbred strains between BALB/cKe and SJL/J mice.
    Sakano T; Wilbur SM; Bonavida B; Cohn M
    J Natl Cancer Inst; 1985 Oct; 75(4):669-73. PubMed ID: 3900512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IA positive reticulum cell sarcoma tumor cell growth in syngeneic SJL/J mice by passive administration of monoclonal anti-IA antibody.
    Sakano T; Bonavida B
    Cancer Res; 1986 Jul; 46(7):3245-8. PubMed ID: 3518916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of spontaneous reticulum cell sarcoma development and of syngeneic stimulator cell by anti-mu treatment of SJL/J mice.
    Katz IR; Asofsky R; Thorbecke GJ
    J Immunol; 1980 Sep; 125(3):1355-9. PubMed ID: 6774017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
    Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
    J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic drift and clonal variation in differentiation antigen expression on AKR T-cell lymphoma lines grown in vitro.
    Howell AL; Richie ER
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):143-54. PubMed ID: 6150437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of SJL/J-derived RCS as related to its ability to induce T cell proliferation in the host. II. Negative influence of H-2d1.
    Katz IR; Chapman-Alexander J; Lerman SP; David CS; Thorbecke GJ
    Transplantation; 1982 Feb; 33(2):134-7. PubMed ID: 7036467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
    Tsiagbe VK; Asakawa J; Miranda A; Sutherland RM; Paterson Y; Thorbecke GJ
    J Immunol; 1993 Jun; 150(12):5519-28. PubMed ID: 8099938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.